CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 28, 2012 CHINA PHARMA HOLDINGS, INC. ----------------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86-898-6681-1730 (China) o o o o]

By | 2016-03-03T18:04:16+00:00 March 2nd, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORT Date of Report

[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 28, 2012 CHINA PHARMA HOLDINGS, INC. ----------------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86-898-6681-1730 (China) o o o o]

By | 2016-03-03T18:05:10+00:00 March 2nd, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] DEF 14A: (Original Filing)

[SCHEDULE 14A INFORMATION INFORMATION REQUIRED IN PROXY STATEMENT x o Check the appropriate box: o o x o o Tianyin Pharmaceutical Co., Inc. Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: Common Stock o (2) Aggregate number of securities to which transaction applies: (3) Per unit price]

By | 2016-03-27T19:38:42+00:00 March 2nd, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] DEF 14A: SCHEDULE 14A INFORMATION INFORMATION REQUIRED IN PROXY STATEMENT

[SCHEDULE 14A INFORMATION INFORMATION REQUIRED IN PROXY STATEMENT x o Check the appropriate box: o o x o o Tianyin Pharmaceutical Co., Inc. Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: Common Stock o (2) Aggregate number of securities to which transaction applies: (3) Per unit price]

By | 2016-03-27T19:39:50+00:00 March 2nd, 2012|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): February 28, 2012 CHINA PHARMAS, ----------------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86-898-6681-1730 (China) o o o o Item 4.02]

By | 2016-02-07T22:11:30+00:00 March 2nd, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORTte of Report (Date

[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): February 28, 2012 CHINA PHARMAS, ----------------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86-898-6681-1730 (China) o o o o Item 4.02]

By | 2016-02-07T22:12:21+00:00 March 2nd, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)

[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 February 28, 2012 VIA EDGAR Division of Corporation Finance 100 F Street, NE Mail Stop: 3561 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 3, 2011 and Amended]

By | 2016-03-03T18:06:14+00:00 February 28th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] SC 13D/A: (Original Filing)

[(Amendment No. 5) TIANYIN PHARMACEUTICAL CO., INC. (Name of Issuer) SCHEDULE 13D/A Common Stock, $.001 par value (Title of Class of Securities) 88630M104 (CUSIP Number) Unit 06, 21/F, Beautiful Group Tower, 77 Connaught Road, Central, Hong Kong Telephone: (852) 3583 3340; Fax: (852) 3585 6021 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 11,]

By | 2016-03-27T19:41:01+00:00 February 24th, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] SC 13D/A: (Amendment No. 5) TIANYIN PHARMACEUTICAL CO., INC. (Name

[(Amendment No. 5) TIANYIN PHARMACEUTICAL CO., INC. (Name of Issuer) SCHEDULE 13D/A Common Stock, $.001 par value (Title of Class of Securities) 88630M104 (CUSIP Number) Unit 06, 21/F, Beautiful Group Tower, 77 Connaught Road, Central, Hong Kong Telephone: (852) 3583 3340; Fax: (852) 3585 6021 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 11,]

By | 2016-03-27T19:42:11+00:00 February 24th, 2012|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar